Endothelial PGC-1α mediates vascular dysfunction in diabetes

Area of Science:

• Vascular Biology
• Metabolic Diseases
• Molecular Endocrinology

Background:

• Endothelial dysfunction is a key feature of diabetes.
• The role of transcriptional coactivator PGC-1α in endothelial cells is not well understood.

Purpose of the Study:

• To investigate the role of endothelial PGC-1α in diabetes-induced vascular dysfunction.
• To determine the mechanisms by which PGC-1α affects endothelial cell function.

Main Methods:

• Assessed endothelial PGC-1α expression in diabetic rodents and humans.
• Utilized cell culture and in vivo models to study endothelial cell migration and vasculogenesis.
• Employed transgenic models with endothelial PGC-1α overexpression and deletion.
• Examined signaling pathways including Notch, Rac/Akt/eNOS, and angiogenic factor responses.

Main Results:

• Endothelial PGC-1α expression is elevated in diabetic conditions.
• PGC-1α inhibits endothelial cell migration, vasculogenesis, re-endothelialization, wound healing, and blood flow recovery.
• PGC-1α induces Notch signaling and blunts Rac/Akt/eNOS activation.
• Deletion of endothelial PGC-1α ameliorates diabetic vascular complications.

Conclusions:

• Endothelial PGC-1α significantly impairs endothelial function and angiogenesis.
• Increased endothelial PGC-1α is a contributing factor to vascular complications in diabetes.
• Targeting endothelial PGC-1α may offer therapeutic potential for diabetic vascular disease.